Livforsakringsbolaget Skandia, Omsesidigt Bio Rad Laboratories, Inc. Transaction History
Livforsakringsbolaget Skandia, Omsesidigt
- $1.72 Billion
- Q3 2024
A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 271 shares of BIO stock, worth $92,142. This represents 0.01% of its overall portfolio holdings.
Number of Shares
271
Previous 71
281.69%
Holding current value
$92,142
Previous $19,000
373.68%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BIO
# of Institutions
457Shares Held
18.2MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.91MShares$649 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$527 Million0.01% of portfolio
-
Van Eck Associates Corp1.3MShares$443 Million0.55% of portfolio
-
Veritas Asset Management LLP1.09MShares$369 Million3.03% of portfolio
-
First Eagle Investment Management, LLC713KShares$242 Million0.5% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.38B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...